Who We Are
Xencor is an innovative, clinical-stage biotechnology company, publicly traded on the NASDAQ stock exchange and located in the Los Angeles area (in Pasadena) and in San Diego. We use our pioneering XmAb® technology to discover and develop better biotherapeutics – antibodies and other proteins with improved function – with the goal of improving patient outcomes and quality of life.